Ascletis is an innovative R&D driven biotech listed on Hong Kong Stock Exchange (1672.HK). Ascletis is committed to developing and commercializing innovative drugs in the areas of NASH, cancer lipid metabolism and oral checkpoint inhibitors, viral hepatitis and HIV/AIDS for unmet medical needs in Ch...See more
Headquarters:
China
Company Type:
MNC / Large Enterprise
Company size:
201-500 Employees
Year Founded:
2013 (12 years)
Address:
浙江省杭州市萧山区杭州湾信息港D栋12楼; 杭州市, 浙江省 311200, CN
At a glanceHIGH
spending power
